Publication | Closed Access

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Drug HypersensitivityAtopic DermatitisModerate-to-severe Atopic DermatitisAdult PatientsClinical TrialsClinical DermatologyPharmacotherapyDermatologyPhase 2SclerodermaMedicine